Default: American Journal of Clinical Oncology: Cancer Clinical Trials

ISSN: 1537-453X

Journal Home

Journal Guideline

American Journal of Clinical Oncology: Cancer Clinical Trials Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

American Journal of Clinical Oncology: Cancer Clinical Trials is a journal indexed in SJR in Oncology and Cancer Research with an H index of 90. It has an SJR impact factor of 0,711 and it has a best quartile of Q2. It has an SJR impact factor of 0,711.

American Journal of Clinical Oncology: Cancer Clinical Trials focuses its scope in these topics and keywords: cancer, patients, breast, cell, chemotherapy, neoadjuvant, therapy, tumor, stereotactic, radiotherapy, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

American Journal of Clinical Oncology: Cancer Clinical Trials

0,711

SJR Impact factor

90

H Index

87

Total Docs (Last Year)

334

Total Docs (3 years)

2755

Total Refs

645

Total Cites (3 years)

309

Citable Docs (3 years)

1.55

Cites/Doc (2 years)

31.67

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, patients, breast, cell, chemotherapy, neoadjuvant, therapy, tumor, stereotactic, radiotherapy, physical, advanced, carcinomatargeting, care, chemoradiation, chemoresistant, chinese, combined, complete, conjunction, conservation, contralateral, cord, cyclophosphamide, dactinomycin, carcinomaradiotherapy, capecitabine, candidatespretreatment, adenocarcinoma, adjuvant, adrenal, advancedstage, alternating, apnea, approaches, association, body, brain, cancerlapatinibgemcitabine, cancerphase,

FAQS